Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 367 | 276 | 272 | 251 | 273 |
| Income taxes - deferred | 228 | N/A | N/A | N/A | N/A |
| Accounts receivable | -3,484 | 9,343 | -4,588 | 4,448 | -2,161 |
| Accounts payable and accrued liabilities | -8,048 | 8,050 | -27,998 | 984 | 12,754 |
| Other Working Capital | -4,975 | -9,734 | -2,075 | 6,450 | 9,011 |
| Other Operating Activity | -34,607 | -31,163 | -36,894 | -45,473 | -53,155 |
| Operating Cash Flow | $-50,519 | $-23,228 | $-71,283 | $-33,340 | $-33,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54 | -87 | 8 | -19 | -44 |
| Net Acquisitions | 37 | N/A | 40 | 22 | 18 |
| Purchase Of Investment | 0 | N/A | N/A | N/A | -6 |
| Other Investing Activity | 512 | -12,655 | 3,232 | 184 | 1,114 |
| Investing Cash Flow | $495 | $-12,742 | $3,280 | $187 | $1,082 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 23 | 0 | 0 | 0 | 0 |
| Debt Repayment | -412 | -40,762 | -5,735 | -6,913 | -6,123 |
| Other Financing Activity | 462 | 1,212 | 609,196 | -1,854 | -1,714 |
| Financing Cash Flow | $73 | $-39,550 | $603,461 | $-8,767 | $-7,837 |
| Exchange Rate Effect | 10,689 | -1,311 | -7,155 | -1,173 | -612 |
| Beginning Cash Position | 516,685 | 589,703 | 60,946 | 103,576 | 144,221 |
| End Cash Position | 477,423 | 516,685 | 589,703 | 60,946 | 103,576 |
| Net Cash Flow | $-49,951 | $-71,707 | $535,912 | $-41,457 | $-40,033 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,519 | -23,228 | -71,283 | -33,340 | -33,278 |
| Capital Expenditure | -54 | -87 | N/A | -19 | -44 |
| Free Cash Flow | -50,573 | -23,315 | -71,283 | -33,359 | -33,322 |